Anti-BCRP/ABCG2 antibody [BXP-21] - Hematopoietic/Neural Stem Cell Marker (ab3380)

ab3380 has been referenced in 16 publications.

1. Watson CP et al. The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood-brain barrier: evidence for involvement of breast cancer resistance protein. Brain Res 1436:111-21 (2012). WB; Human. PubMed: 22200378
2. Kinsella P et al. Imatinib and docetaxel in combination can effectively inhibit glioma invasion in an in vitro 3D invasion assay. J Neurooncol 101:189-98 (2011). WB; Human. PubMed: 20512610
3. Hardwick RN et al. Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease. Drug Metab Dispos 39:2395-402 (2011). WB, IHC-P; Human. PubMed: 21878559
4. Shi P et al. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus. Cancer Epidemiol Biomarkers Prev 19:844-9 (2010). IHC-P; Human. PubMed: 20200437
5. Jemnitz K et al. Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes. Toxicol In Vitro 24:605-10 (2010). PubMed: 19853032
6. Su C et al. Guanosine-induced decrease in side population of lung cancer cells: lack of correlation with ABCG2 expression. J Biol Regul Homeost Agents 24:19-25 (2010). WB; Human. PubMed: 20385068
7. Holpuch AS et al. Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies. Pharm Res 27:1224-36 (2010). WB, IHC-P; Human. PubMed: 20354767
8. Zhang P et al. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett 277:227-34 (2009). ICC/IF. PubMed: 19185988
9. Mannermaa E et al. Efflux protein expression in human retinal pigment epithelium cell lines. Pharm Res 26:1785-91 (2009). WB; Human. PubMed: 19384462
10. Kis E et al. Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance. Ann Rheum Dis 68:1201-7 (2009). PubMed: 18397960
11. Pál A et al. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2. J Pharmacol Exp Ther 321:1085-94 (2007). PubMed: 17347325
12. Glavinas H et al. ABCG2 (breast cancer resistance protein/mitoxantrone resistance-associated protein) ATPase assay: a useful tool to detect drug-transporter interactions. Drug Metab Dispos 35:1533-42 (2007). PubMed: 17537873
13. Iohara K et al. Side population cells isolated from porcine dental pulp tissue with self-renewal and multipotency for dentinogenesis, chondrogenesis, adipogenesis, and neurogenesis. Stem Cells 24:2493-503 (2006). PubMed: 16873765
14. Janneh O et al. Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP. AIDS 19:2097-102 (2005). PubMed: 16284458
15. Xia CQ et al. Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells. Drug Metab Dispos 33:637-43 (2005). PubMed: 15716365
16. Maliepaard M et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61:3458-64 (2001). PubMed: 11309308